This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Doris Domin: Innovator in Pharmaceutical Chemistry
Introduction
Doris Domin is a prominent inventor based in Vienna, Austria, known for her contributions to pharmaceutical chemistry. With a total of two patents to her name, she has made significant strides in the field of drug development.
Latest Patents
Doris Domin's latest patents include a process for the preparation of an enantiomeric trisubstituted 3,4-dihydro-isoquinoline derivative. This invention relates to a process that involves the hydrogenation of a specific compound using a unique catalyst. Another notable patent is for a trisubstituted 3,4-dihydro-1H-isoquinolin compound, which details both the process for its preparation and its potential uses.
Career Highlights
Doris Domin has established herself as a key figure in her field, working with Actelion Pharmaceuticals Ltd. Her innovative approaches to drug synthesis have garnered attention and respect within the pharmaceutical community.
Collaborations
Throughout her career, Doris has collaborated with esteemed colleagues such as Matthias Helms and Christoph Imboden, contributing to a dynamic research environment that fosters innovation.
Conclusion
Doris Domin's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents reflect her commitment to advancing drug development and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile